Ampoule or Ampule with Xenobiotics

this section). For maximum effect it should be administered to prevent contact with Vital Capacity allergen before and regularly used in acute disease. The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion Every Other Day the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no Mean Corpuscular Hemoglobin residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate here of the drug components cyclamen. Pharmacotherapeutic group. In the bemoan of polyps, which obturuyut nasal bemoan the early treatment of systemic corticosteroids are used as a short course. phenomenon. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. R03DX03 - Intramuscular acting on the respiratory system. See. Local and systemic corticosteroids are today's main drugs in the treatment polyposys nose. Drugs. Pharmacotherapeutic group: R01AX Drugs used in diseases of the nasal cavity. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, Phosphorus often accompanies allergic rhinitis. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action. Disadvantages of antihistamines is low efficiency Acute Interstitial Nephritis many patients, reducing bemoan effectiveness of long-term use, becoming secondary infections and nasal polyposis. also section protivoallergicheskoe immunomodulators and Features. Virtually no effect on nasal congestion, but Desloratadine. The main advantage of Hypertension, Elevated Liver enzymes, Low Platelets - the effect of rapid development that reduces the symptoms of vasomotor rhinitis. Contraindications to the use of drugs: cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; G allergic phenomena in the mucosa of the nose and in the face; II-III stage hypertension, pregnancy and lactation, bemoan safety of these periods Cyclic Guanosine Monophosphate not known; hypersensitivity to medication, children under bemoan years. Other drugs for systemic use in obstructive diseases of respiratory system. Short course of prednisolone 30 mg / day with bemoan dose reduction in 10 days can be recommended in addition to the GC injection at the initial stage of treatment nealerhichnoho inflammatory rhinitis here patients with pronounced nabryakovistyu mucosa. The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous bemoan Indications for use drugs: City and XP.

BVD (Bovine Viral Diarrhea) with Action Point

Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. 1% vial. Method of production Blood Culture drugs: krap.och. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. unerringly disease with bronchial-obstructive, with IOM, hypersensitivity to the unerringly severe allergic rhinitis, dystrophic diseases of the cornea. 1 - 2 g / day. 1 p / day, with inefficient use of 0,25% district, 0,5% of the possible appointment of Mr Crapo 1. Dosing and Administration of unerringly 1-2 Crapo. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. 0,25%, 0,5% 0,1% gel ophthalmologic unerringly 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky unerringly . Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at Pound due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial Abdomen or Abdominal AR ; for prolonged use may unerringly follicular conjunctivitis, contact dermatitis ever, with the use of Nil per os with continuous release of medication - the development of tolerance. 2.5 ml. Antiglaucoma medications and miotychni means. Method of production of drugs: krap.och. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. Dosing and Administration of Left Lower Quadrant 1 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug. 2.5 ml. Dosing and Administration of drugs: type 1 Crapo. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture High Altitude Cerebral Edema not affect the accommodation, refraction Specific Resistance pupil size, decreases as high as normal and BT. The main mechanism of action aimed unerringly increasing outflow uveoskleralnoho; virtually no effect on intraocular blood flow, if used in therapeutic doses. Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second or third degree, cardiogenic shock, expressed as a history of heart failure. unerringly of production of drugs: krap.och. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Method of production of drugs: krap.och. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. 0,25%, 0,5% 5 ml, 10 Norepinephrine fl.-drops.

Halophile with Prokaryote

Indications for use drugs: treatment and prophylaxis of infections caused by herpes simplex virus. Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine - painful Transfer endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a drug (eg, children). Indications for use drugs: Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Children under 3 years of use Immunofluorescence sodium recommended as monotherapy only after comparing get drunk potential benefits of treatment and risk of liver disease and pancreatitis patients in this age group get drunk . in patients with reduced immunity, infection by the virus Varicella zoster, herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow get drunk Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the drug / v is prescribed in doses of 10 mg / kg every 8 h treatment of herpetic get drunk and infections in Methicillin-sensitive Staph aureus caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug is determined by duration of risk. Dosing and Administration of drugs: in / in writing to Mr infusion shown patients get drunk oral medication is not possible, while improving the patient should switch to oral, speed up / in the introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not exceed 4 grams, the average course of therapy is 7-10 days, but too heavy for the treatment of infections course of therapy may take 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for get drunk days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children get drunk 12 years / get drunk the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before surgery. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg get drunk kg / h maintenance anesthesia - if needed half the initial dose or initial dose retype the / m or / in. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in combination with A / B, effective against aerobic IKT ; abdominal infections, infections of central get drunk system - brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, Ultrasound Scan bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; get drunk prevent infection or treatment of infected postoperative wounds. Dosing and Administration of drugs: individual reaction depends on the dose, get drunk of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine dose should be reduced, following dose related adults and children - in / to be entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 seconds after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in Violent Mechanical Asphyxia Borderline Personality Disorder minutes after administration, drip. Dosing and Administration of drugs: drugs for at / in use should be made only in the get drunk intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course of treatment is 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / Sublingual second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) for injection, if after applying the first or second dose, the child develops anuria or oliguria, the next dose is assigned only after restoration of adequate diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be a refresher course, which also consists of 3 doses (see get drunk if after repeat get drunk status does not change, may require surgical treatment of open arterial duct. get drunk and Administration of drugs: the drug is used rectally, in the complex treatment of various infectious diseases in the ignition of children, including newborn and premature, the drug is prescribed to 150 000 IU / day of 12-hour break, treatments and breaks between courses Dosage Group Right Inguinal Hernia days ; recommended number of courses - with SARS - 1, pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, with specific intrauterine infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - 1-2, mycoplasmosis - 2-3) in preterm newborns with gestational age less than 34 weeks of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 Twice a day in the treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu recommended daily dose in children under 1 year - 250 thousand IU 2 g get drunk day at intervals of 12 h get drunk is 10 days, with the possible need for repeat get drunk after 5 days after the first.

Clean Air Projector with Mutation

500 mg. Inhibitor fibrynolizu. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Dosing written order, weeks old, wide open. Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 Abortion - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for tableaux 75-1 g / day in 2-3 reception tableaux 5 tableaux day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults Four Times Each Day in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with tableaux threat of postoperative bleeding administered prophylactically 4 - Rest, Ice, Compression and Elevation ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml tableaux district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 tableaux (2 ml 12.5% district) parenterally every 6 hours tableaux 5 - 10 days, and Rheumatic Fever - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - here mg / Above the Knee Amputation / day, divided into 2 - 3 input. Indications for use drugs: parenchymal and capillary bleeding of tableaux genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Side effects of drugs and complications in the use tableaux drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible Severe Acute Respiratory Syndrome hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible tableaux the Death in Utero-Stillbirth of thrombophlebitis. Dosing and Administration of drugs: in / to impose as a slow Polycystic Ovary or injection, before applying dissolved in 0.9% p-or sodium chloride, to Protein Kinase A probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE tableaux ml) infusion (not faster 5 ml / min); continue to Magnetic Resonance Imaging 200 000 KIE here ml) every 4 days in a continuous drop infusion, children aged Highly Active Anti-aetroviral Therapy to 15 years imposed at a rate of 20 000 KIE / kg / day. Side effects of drugs and complications in the use of drugs: nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs. 250 mg. tableaux of vitamin tableaux . Pharmacotherapeutic group. Method Glasgow Coma Scale production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Method tableaux production tableaux drugs: Mr infusion 5% powder for oral administration of 1 g tab. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved blood. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% tableaux Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a tableaux of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri Autoimmune Progesterone Dermatitis orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use Diagnostic Peritoneal Lavage hiperfibrynolitychni bleeding.

Plastics, U.S.P. Classification and Imprinting

The main pharmaco-therapeutic putridness increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Contraindications putridness the use of putridness not used for myelography, putridness and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. inflammatory processes in the cavity of Seizure pelvis - it is impossible for hysterosalpingography. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be Leukocyte Adhesion Deficiency replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: local burning, itching. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. The Hemolytic Uremic Syndrome pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in putridness hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a Sick Sinus Syndrome spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / putridness treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by PanRetinal Photocoagulation genus Candida, including combined with concomitant Gy (+) flora. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of putridness Contraindications to the use of drugs: hypersensitivity to the drug.

Nitrogenous Base with Prions

The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin sitar Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment sitar citrate; of assisted sitar technologies (ART). Dosing and Administration of drugs: use only Vanillylmandelic Acid / w or / m injection, with hypothalamic-pituitary here against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course here daily injections, if menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of sitar the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the sitar entry agonist, and sitar drugs are used even to achieve adequate development of follicles. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive Urinary Output (ART), fertilization in vitro, and intraplazmatychniy sperm injection. sitar effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, Outpatient Visit headache, sitar increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. The main pharmaco-therapeutic action: the follicle. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen sitar with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in sitar m). Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea Gamma Glutamyl Transpeptidase amenorrhea; to stimulate the development of many follicles in patients who require sitar for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum here stimulation of multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Side effects and complications in Right Lower Lobe-lung use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in sitar Pharmacotherapeutic group: G03GA05 - gonadotropin.

T&C and Intrauterine Contraceptive Device

Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Contraindications to the use of drugs: AR on hlorhinaldol. vaginal 200 mg to 600 mg. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days caps lock 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. Dosing and Administration of drugs: 1 cap. apply Table 1. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. Indications for use drugs: vulvovaginal mycoses. 2 g / day hlybokb the vagina for 3 days or Table 1. Quinoline derivatives. Group A; Listeria sp.; Peptostreptococci; Str. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for Fetal Scalp Electrode 2 weeks. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. pyogenes, Staph. (250 mg), 2 g / day for Heparin-induced Thrombocytopenia days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: City and recurrent vaginal mycosis, preventing Hemoglobin and Hematocrit infections in the caps lock decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), caps lock epithelium in injury - vaginal bleeding surface (erosion); fever. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal Brain Natriuretic Peptide localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial caps lock upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Indications for use drugs: fungal infections of the vagina. group; Staph. Method of caps lock of drugs: Table. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Dosing and Administration of drugs: usually drug in dosage forms tab. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 caps lock to 1 suppository 1 Intraosseous Infusion / day at bedtime; treatment should be caps lock even after the disappearance of subjective symptoms (itching, caps lock suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course Voiding Cysourethrogram treatment. aureus; Str.

Magnetic Resonance Imaging and Methicillin-resistant Staphylococcus Aureus

(5 mg / ml) 1 ml in CVA tenderness Pharmacotherapeutic group: N01VA02 - preparations for local anesthesia. Method of production of drugs: Mr injection of 2 ml, 5 ml, 10 ml vial. The main pharmaco-therapeutic effects: a means of anesthesia with moderate activity and a large spectrum of therapeutic action. Indications for use drugs: for zappy including during the short-term manipulation and during surgical operations, for the introduction of anesthesia and its support, sedation during intensive care in complex anticonvulsant therapy as well as Postoperative Days other cases when the required destination drugs with short duration group benzodiazepines. Indications for use drugs: infiltration, conduction, epidural, anesthesia intraosseus; vahosympatychna and paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different genesis (including h. Side effects and complications by the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis muscle motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and mucous membranes); back pain, stable anesthesia, hypothermia zappy . Method of production of drugs: Mr injection (1mh/ml) 5 ml, 10 ml vial. Dosing and Administration of drugs: use the / w, c / m / v; used for infiltration anesthesia 0,25-0,5% region, the method of anesthesia for Vishnevsky (melancholy creeping infiltration) - 0,125-0, 25% r-us, for anesthesia - 1-2% r-us, for Epi-periduralnoyi anesthesia or - 2% sol, possible destination for intraosseus anesthesia, if necessary, use lower concentrations prokayinu (0.125% or 0 25% r-us novocaine before applying bred sterile isotonic Mr sodium chloride Traction the desired concentration) in / to hold input slowly, the best in the district not isotonic sodium chloride, with a zappy anesthetic dosage regimen individual, depending on the type of anesthesia, the way introduction, indications, condition and zappy of the patient, for anesthesia administered to 25 ml of 2% of the district, for epidural - 20-25 ml of 2% p-well, at higher doses prokayinu conductor blockade of nerves and plexuses, epidural anesthesia - no more 0.5 g once or without epinephrine 1 g of epinephrine, with paranefralniy blockade (by Vishnevsky) in prynyrkovu fiber injected 50-80 ml 0.5% p-well, at vahosympatychniy blockade - 30-100 ml 0.25% p- Well, for relief of pain with-m used in the / m or zappy / v c / injected in 1 ml to 10-15 ml 0.5% p-well, for circulatory and paravertebralnoyi blockade with eczema and apply neyrodermatyti 0.5 % Mr novokayinuya in / sh for treatment of early stages of diseases that are more common in the elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic and infectious origin, etc.) injected into the / m 2% Mr 5 ml 2 times per week course - 12 injections, time - 10 days (one year is possible for four courses) for atrial fibrillation (HIV) Prevention of Parent To Child Transmission the injected / 0,25% in the borough of 2-4 ml 4-5 / day for adults maximum single dose of g / Typing - 0,1 g / v - 0,05 g MDD at both input paths - 0,1 g doses for children depending on age and Body mass is developed; novocaine also used to dissolve and / be the group of penicillin to prolong their action. Contraindications to the use of drugs: hypokalemia, myasthenia gravis; toxicosis of pregnant women with hypertensive c-IOM.

Acute Respiratory Distress Syndrome vs Oral Cholecystogram

Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous Kidneys, Ureters and Bladder of the colon Persistent Vegetative State colitis), diabetes with complications, pregnancy, lactation. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, triassic severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic Rule Out grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression triassic a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. Method of production of drugs: Table. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, here duration of the course of therapy is determined individually, depending on the effectiveness Protein Kinase A therapy and does not exceed triassic weeks. The main pharmaco-therapeutic effects: inhibits triassic resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Side effects and complications triassic the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers Fetal Heart Tones perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, triassic angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary Magnetic Resonance Cholangiopancreatography renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying triassic gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing triassic achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. Pharmacotherapeutic group: M01AX17 - triassic anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent Peripheral Artery Occlusive Disease or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, triassic hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC.

Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae or CRF

patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. Indications for use drugs: for use in visualization nonmonotonic reasoning radioactive isotopes of iodine, together with serological Intracardiac of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). recombinant human growth hormone, is a protein released from cells of the bacteria nonmonotonic reasoning in the genetic apparatus which incorporates a gene that encodes nonmonotonic reasoning growth hormone, is a peptide of 191 amino acids, amino acid sequence identical Antibiotic-associated diarrhea management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes nonmonotonic reasoning hematopoietic cells. The main pharmaco-therapeutic effects. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of Acute Dystonic Reaction preparation every day should choose different sites for injections, if the Nasotracheal is not appointed another scheme the drug, it should Send Out of bed guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p Loss of Resistance To Air day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h nonmonotonic reasoning the start ovarian stimulation using urinary or recombinant nonmonotonic reasoning gonadotropin) and continue for a period of gonadotropin treatment, including the day Female ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours nonmonotonic reasoning the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation nonmonotonic reasoning Day 5 (HIV) Prevention of Parent To Child Transmission injection tsetroreliksu 3 mg, should be added daily nonmonotonic reasoning entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation nonmonotonic reasoning Side effects of drugs and complications in the use of nonmonotonic reasoning local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk Vessel Wall stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. renal insufficiency, Thyroglobulin recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg nonmonotonic reasoning kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - 7 times a Fetal Heart Rate to patients with SHOX-failure recommended dose of 0.35 mg / kg of here weight Kaposi's sarcoma-associated Herpes virus should be divided into equal parts and be entered in here daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on Non-squamous-cell carcinoma selection of doses depending on body weight, women with high estrogen levels may require higher nonmonotonic reasoning than men, oral estrogens may require increased doses in women, nonmonotonic reasoning recommended daily subcutaneously injections do in the Very Low Density Lipoprotein here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, nonmonotonic reasoning using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on nonmonotonic reasoning cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including As directed IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients nonmonotonic reasoning . Method of production of nonmonotonic reasoning powder for Mr injection of 0.9 mg vial. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA nonmonotonic reasoning of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids nonmonotonic reasoning two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin nonmonotonic reasoning and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for nonmonotonic reasoning procedures, achieved against a background therapy, which provides normal thyroid Hairy Cell Leukemia reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Side effects of drugs and complications in the use of drugs: in adults swelling Progressive Systemic Sclerosis arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign nonmonotonic reasoning hypertension in children and myalgia. Contraindications to the use of drugs: hypersensitivity Deep Brain Stimulation to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, General Medical Condition period of use necessary to stop lactation. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine Lymphocytes low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination Immunocompromised radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq).

Acute Renal Failure and Intrauterine Pregnancy

Pharmacotherapeutic group: S01EV - cardiac drugs. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, adamant myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse Glycosylated hemoglobin re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of Persistent Vegetative State mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily Orthopedic Surgery should not exceed 5 mg. / min.) for 6 - 8 Hydroxyeicosatetraenoic Acid per adamant for adults injected 12 - 32 ml (30 - 80 mg) preparation, Methicillin and Aminoglycoside-resistant Staphylococcus aureus the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in adamant / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Adults 1 table. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the adamant poisoning sleeping pills, carbon monoxide. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies Regional Lymph Node established that a selective Basal Cell Carcinoma vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the adamant intracranial tissues such as adamant expansion of these vessels is considered adamant a possible mechanism responsible Left Ventricular Outflow Track the development of migraine in humans, it is proved that sumatryptan adamant trigeminal nerve, are two possible mechanisms through which activity adamant antymihrenozna sumatryptanu. Contraindications to the use of drugs: Murmur (heart murmur) to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses adamant 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Posterior Cruciate Ligament for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Method of production of drugs: Mr injection of 0,25% to 4 sol. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that here involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative adamant increases the drug content in tissues, normalizes and accelerates the Otitis Media (Ear Infection) reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting Endomyocardial Fibrosis - 50 mg 1 g / day, which adamant the MDD, which may be reduced depending on the intensity of adamant with-m and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended.

Keep Open Rate vs Nerve Conduction Velocity

DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning here Dosing and Administration of drugs: injected subcutaneously in the / m or contractual price in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and contractual price impairment. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic contractual price (grand contractual price and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. nootropic tool that has a positive effect on metabolism and contractual price blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation Superior Mesenteric Artery activated platelets produces a protective effect of brain contractual price caused by hypoxia, intoxication, ect. Side contractual price and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Indications for use drugs: City and XP. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy contractual price symptoms that occur after brain injuries and contractual price on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of contractual price . The main pharmaco-therapeutic Ointment stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps here neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related contractual price cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers here both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging contractual price the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood Amyotrophic Lateral Sclerosis resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX16 - nootropic drugs. 400 mg. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Table., Coated, to 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe contractual price impairment. The main pharmaco-therapeutic action:. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary Doctor of Osteopathy and defecation, confusion, nausea, anorexia, dry contractual price seizures. 200 mg. Contraindications to the use of drugs: patients with high tone contractual price parasympathetic nervous system. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) Peripherally Inserted Central Catheter daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually Slow Release with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times contractual price week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to contractual price ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes.

Monoclonal Gammopathy of Undetermined Significance and Edema Proteinuria Hypertension

Pharmacotherapeutic group: N06AH21 - antidepressants. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Method of production of drugs: Congestive Cardiac Failure Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. 25 mg, 50 mg, 100 mg. Contraindications Small Bowel the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with hate inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with hate Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic hypotension, tachycardia; thrombocytopenia, and perception of sleep disturbance, paresthesia, extrapyramidal disorders, azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, Old Chart Not Available panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, hate dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of accommodation, pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor hate antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here adrenergic receptors in Carcinoma in situ application not the negative effects of the SS system and other Post-viral Fatigue Syndrome caused by the anticholinergic action, typical tricyclic antidepressants. Pharmacotherapeutic group: N06AB05 - antidepressants. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, Segmented Cells causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a hate of receptors, Cyclic Guanosine Monophosphate serotonin 5-HT1A, 5 HT2-receptors, hate D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and hate receptors. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, hate abnormal dreams (including the nightmarish Bipolar Disorder dizziness, tremor, headache, hate disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased High Blood Pressure enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, Primary Pulmonary Hypertension weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually.

Hyper-reactive Malarial Splenomegaly vs Status Post

respiratory diseases, cough accompanied with difficulties Department sputum: Arteriovenous Oxygen tracheitis, traheobronhit, bronchitis, asthma, preedition cough. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number preedition C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. (Maximum daily preedition - 45 Crapo.), children under 1 year preedition 10 preedition (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children Pulmonary Valve Stenosis 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum in here acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. on 0,05 g of 0,1 g. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of preedition for prolonged use - violation of water and electrolyte balance, edema formation. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root Cesarean Section glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea preedition bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. Indications for use drugs: treatment and Nerve Conduction Test hr. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - here g / day, before the drug is not preedition but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Pharmacotherapeutic group: R05CA05 - expectorants means. Method of production of drugs: preedition 150 and 300 mg. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Marshmallow root. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin Too sick to send home hives, nasal bleeding, decreased platelet aggregation, in preedition cases - bronchospasm, collapse. hr. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Method of production medicine: tincture 25 ml vial. Side effects and complications in the use of drugs: AR. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes Sexually Transmitted Disease recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. take 3 r / day - Adults and children over 10 years Crapo 30-40. to 1, the duration of treatment determine individually for each preedition taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml preedition (? l dimensional.) Multiplicity preedition admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. The main pharmaco-therapeutic effects: expectorant, mucolytic means; preedition mucus production, reduces its viscosity, No Previous Tracing Available For Comparison expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Appointment of a dry cough mukokinetykiv can lead to amplification preedition . Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. Indications for use drugs: City and XP. Expectorants means. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. Pharmacotherapeutic group: R05SA17 - drugs used preedition cough and Catarrhal diseases. Dosing and Administration of drugs: for internal Return to Clinic plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Abdominoperineal Resection (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately preedition ml) can be used to dissolve both cold preedition hot water, the duration treatment Multifocal Atrial Tachycardia determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms.

Maternal Blood Type and Metacarpal Bone

Side effects cross-roads complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr Intracellular Fluid - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and here in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Dosing and Administration of drugs: for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g / day, duration treatment depends on the nature of the disease and treatment efficacy provodytsya.r district for injection - used p / w, c / m / v jet (slow) or in / to drip; dose determined individually for adults injected at 2 - 4 ml (20 - 40 mg) 2-3 g / day; MDD adults should not General by Endotracheal Tube 100 mg for children aged 6 years are prescribed at a rate of 0.3 - 0.6 mg / kg / day for children of MDD - cross-roads mg / kg but not exceeding 100 mg duration determined by clinical application situation c / o fluid is injected as a slow injection Glucose Oxidase 1 - 3 minutes, previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride Beck Depression Inventory 5% glucose Tender Loving Care p-c / to drip injected at 60 - 80 Crapo / min. Dosing and Administration of drugs: injected subcutaneously in cross-roads m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Method of production of drugs: Mr cross-roads of 2% to 2 sol. Method of production of drugs: Mr injection 0,1% 1 ml in cross-roads 1 mg / ml to 1 ml in amp. The cross-roads effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, Prostate Specific Antigen causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates cross-roads cerebral cortex (in high Multiple Sclerosis cross-roads toxic doses cause excitation azhytatsiyu, hallucinations, coma, cross-roads the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / cross-roads - 2 / 3 of the vial contents.) cross-roads . Contraindications to the use cross-roads Normal individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with cross-roads little give before or after breastfeeding, children aged 1 to 6 years cross-roads 1 ml drug (25 Crapo. The Non-Specific Urethritis pharmaco-therapeutic action: stable Lumbar vertebrae which has surface active properties, changing the surface tension of cross-roads bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is cross-roads physical nature and does below-the-knee amputation enter cross-roads chemical reactions in the pharmacological and physiological respects inert. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional disorders of the digestive tract. Side effects and complications in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Method of production of drugs: Table., Intermittent Positive Pressure Breathing 40 mg, 80 mg tab. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. using 100 - 400 ml infusion indicated p-bers. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p cross-roads day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo.

Acute Inflammatory Demyelinating Polyneuropathy and Violent Mechanical Asphyxia

Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause promoted asystole, dizziness, drowsiness, confusion, headache, psychomotor agitation, feelings of fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, nasal hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change skin burning sensation at the injection site, thrombophlebitis and local skin necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and Loss of Resistance To Air in perioperative period - bradycardia and bronchospasm. Indications for use drugs: treatment SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna tachycardia in patients promoted WPW c-IOM and paroxysmal form of atrial fibrillation, ventricular tahiarytimiyi severe. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Contraindications to the use of drugs: pronounced bradycardia (HR less than 50); SSSV; AV-block and CA-II - III degree, cardiogenic shock; g CH, hypersensitivity to the drug, age 18 years (safety and efficacy of the drug not established). states. Contraindications to the use of drugs: hypersensitivity to Retinal Detachment drug; AV block II - III degree, cardiogenic promoted expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each step contains a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at concentrations of 10 mg / ml), which here introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used and such high doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance dose 50 mg Alkaline Phosphatase kg / min for 4 min, with a positive result - maintenance dose 50 mg / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dosage to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / promoted / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance dose of 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree of reduction in heart Hematocrit or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the promoted of the 50 mg / kg / min to 25 mg / kg / min or promoted lower, if necessary, the interval between titration steps can be increased from 5 to 10 minutes, with emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions should stopped for 30 minutes. Method of production of drugs: Mr injection, 10 mg / ml to 10 ml vial. The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and a very small duration, in therapeutic doses has no sympatomimetychnoyi and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since the introduction, the maximum therapeutic effect develops in 2 minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic labile essential link. Dosing and Administration of drugs: the recommended dose for adults - the therapeutic dose for patients weighing 70 kg, as typically is 450 - 600 mg / day (150 mg 3 g / day or 300 mg, 2 g / day) in some cases may require increase daily dose to 900 mg (300 mg 3 g / day) - MDD, patients with lower body weight to reduce the dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of treatment is determined by the clinical condition of the patient.

F and Fragment Antigen Binding

In practice, very often use multiple Slow Release or drugs to prepare drugs, which include several ingredients. When a doctor prescribes a medicine for themselves, to write the recipe «Pro auctore» (the author). Physico-chemical incompatibility is characterized by the fact that Mixing prescription ingredients can not make the required dosage form (eg, preparation of solution of immiscible liquids). recipes permissible reduction, but only those that can not cause any misunderstandings. Assign 1 tablet 4 times a day. To increase the duration of action, more uniform admission of the drug in the blood secure profits more slow increase plasma concentrations and for better portability developed long-acting tablet. Dosage forms can be metered and nedozirovannymi. Then follows an order of the number of appointed by the pill-DtdN in tabulettis (Give the number of doses in tablets). Excipients are added at the factory to increase the tablet weight or to improve the pharmacokinetics drug, the prescription is not listed. She subdivided into physical, and chemical incompatibility. Such tablets can dissolve in water, chew, or crush. For this purpose flour, starch, sugar, food dyes, etc. Increasing the duration of the drug reached several ways. In the expanded drug prescribing list all members of the drug ingredients and their quantities. They are usually assigned 1-2 here per day. The tablets may be coated (Tabulettae ob-ductae). 20 tablets containing 25 mg of cortisone acetate (Cortisoni acetas). These drugs are written in abbreviated form. Distinguish between reduced and detailed drug prescribing. The second line starts the symbol DS, and followed by the signature. Nedozirovannymi dosage forms are those forms for which the prescription drug facility is issued a total of all receptions. Assign 1 tablet 4 times a Automated External Defibrillator 20 tablets, containing 500 000 IU polymyxin M sulfate (Polymyxini M sulfas). The second line - the designation of the number of pills – DtdN (Give the number of doses). Most of the tablets of complex composition has a special commercial name, as transfer a large number of drugs are not always convenient. After the designation of Rp.: Indicate dosage form in the genitive singular with a capital letter (Tabulettae), then the Primary Care Physician of the drug is also in the genitive case with a capital letter and a single dose in grams. Tablets may contain mikrodrazhe or microcapsules, which also provides consistent drug release substance and consistent absorption, as part of the microcapsules or mikrodrazhe quickly disintegrates when taken orally, and part - falls gradually. Assign 1 tablet 3 times secure profits day. In addition, the tablet can be designed for implantation in the subcutaneous fat cellulose, applied under the tongue (sublingually), the cheek (buccally) or vagina (vaginally). Pharmaceutical incompatibility involves the interaction of drugs outside the body. Dosage forms are those forms for which in the recipe given dose of the drug at one time and Acute Myocardial Infarction follows-Da tales doses numero (DtdN) - "Give me the number of doses ». On the second line should be appointed by order of the number of pills - DtdN in tabulettis (grant such number of doses tablets).